ArticleImmunotherapy2025

Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.

Atefeh Yari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.